Oncology & Cancer

SABCS: PD 0332991 + letrozole studied in ER+ breast cancer

(HealthDay)—For women with estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, the investigational agent PD 0332991 plus letrozole improves progression-free survival versus ...

Health

BPA can adversely affect parenting behavior in mice

Biparental care of offspring, or care that is administered by both parents, occurs in only a minority of species, including humans. Past studies have shown that maternal care can be negatively affected when females are exposed ...

Oncology & Cancer

Endocrine therapy lowers QOL for breast cancer patients

(HealthDay)—Endocrine therapy reduces the quality of life of breast cancer patients, especially for postmenopausal women, according to a study recently published in the Annals of Oncology.

Oncology & Cancer

Imaging agents predict breast cancer response to endocrine therapy

Research published in the July issue of The Journal of Nuclear Medicine shows imaging progesterone receptor (PR) status also may be able to identify responders and nonresponders to endocrine therapy at an early stage. Estrogen ...

page 12 from 21